Targeting androgen receptor phase separation to overcome antiandrogen resistance
Patients with castration-resistant prostate cancer inevitably acquire resistance to
antiandrogen therapies in part because of androgen receptor (AR) mutations or splice …
antiandrogen therapies in part because of androgen receptor (AR) mutations or splice …
Targeting androgen receptor phase separation to overcome antiandrogen resistance
J Xie, H He, W Kong, Z Li, Z Gao… - Nature chemical …, 2022 - pubmed.ncbi.nlm.nih.gov
Patients with castration-resistant prostate cancer inevitably acquire resistance to
antiandrogen therapies in part because of androgen receptor (AR) mutations or splice …
antiandrogen therapies in part because of androgen receptor (AR) mutations or splice …
Targeting androgen receptor phase separation to overcome antiandrogen resistance.
J Xie, H He, W Kong, Z Li, Z Gao, D Xie… - Nature Chemical …, 2022 - europepmc.org
Patients with castration-resistant prostate cancer inevitably acquire resistance to
antiandrogen therapies in part because of androgen receptor (AR) mutations or splice …
antiandrogen therapies in part because of androgen receptor (AR) mutations or splice …